Drug · DIN 02437503
JINARC
COMBINATION PACK CONTAINING: A) 15 MG TABLET AND B) 45 MG TABLET
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since June 1, 2015; first marketed June 1, 2015.
- Drug Identification Number (DIN)
- 02437503
- Company (DIN owner)
- Otsuka Pharmaceutical Co LtdChiyoda-Ku Tokyo, --, Japan
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Tolvaptan C03XA01
- Class
- Human
- Record last updated
- September 21, 2026
Active ingredients
As listed in the Drug Product Database.
Notices of Compliance
Health Canada approvals that name this DIN.
- February 25, 2015: NOC 16640New Drug Submission (NDS)
Other DINs named JINARC
- DIN 02437511 · Marketed
- DIN 02437538 · Marketed
- DIN 02491575 · Marketed
- DIN 02491583 · Marketed